Artiva Biotherapeutics (ARTV) FCF Margin (2023 - 2024)

Historic FCF Margin for Artiva Biotherapeutics (ARTV) over the last 2 years, with Q1 2024 value amounting to 6017.53%.

  • Artiva Biotherapeutics' FCF Margin changed N/A to 6017.53% in Q1 2024 from the same period last year, while for Dec 2024 it was 22180.88%, marking a year-over-year change of. This contributed to the annual value of 22180.88% for FY2024, which is 220295300.0% down from last year.
  • Artiva Biotherapeutics' FCF Margin amounted to 6017.53% in Q1 2024.
  • Artiva Biotherapeutics' FCF Margin's 5-year high stood at 40.99% during Q3 2023, with a 5-year trough of 6017.53% in Q1 2024.